Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
Alector
ALEC
$208M
| $91.6K | ﹤0.01% |
42,591
-356,096
| -89% | -$715K |
2019 Q1
28 quarters
|
|
4002
Global X Autonomous & Electric Vehicles ETF
DRIV
$357M
| $91.6K | ﹤0.01% |
3,000
| – | – |
2021 Q1
20 quarters
|
|
4003
Union Bankshares
UNB
$114M
| $91.5K | ﹤0.01% |
3,763
-4,779
| -56% | -$115K |
2024 Q3
6 quarters
|
|
4004
Citizens & Northern Corp
CZNC
$452M
| $91K | ﹤0.01% |
4,073
-22,874
| -85% | -$507K |
2016 Q1
40 quarters
|
|
4005
Sana Biotechnology
SANA
$865M
| $91K | ﹤0.01% |
31,580
-478,309
| -94% | -$1.88M |
2022 Q1
16 quarters
|
|
4006
HealthStream
HSTM
$929M
| $90.9K | ﹤0.01% |
4,391
-32,741
| -88% | -$697K |
2016 Q2
39 quarters
|
|
|
ACB
4007
Aurora Cannabis
ACB
$247M
| $90.6K | ﹤0.01% |
27,717
-5,992
| -18% | -$22.6K |
2022 Q1
16 quarters
|
|
4008
FT Vest US Equity Moderate Buffer ETF April
GAPR
$295M
| $90.5K | ﹤0.01% |
2,236
+2,226
| +22,260% | +$89.5K |
2024 Q3
6 quarters
|
|
4009
AllianzIM U.S. Equity Buffer20 Sep ETF
SEPW
$124M
| $90.5K | ﹤0.01% |
+2,864
| New | +$91.5K |
2026 Q1
0 quarters
|
|
4010
iShares Asia 50 ETF
AIA
$4.95B
| $90.2K | ﹤0.01% |
850
-2,910
| -77% | -$318K |
2020 Q1
24 quarters
|
|
4011
FVCBankcorp
FVCB
$317M
| $90.2K | ﹤0.01% |
5,939
-26,771
| -82% | -$402K |
2022 Q2
15 quarters
|
|
4012
Tonix Pharmaceuticals
TNXP
$158M
| $90K | ﹤0.01% |
6,549
-15,682
| -71% | -$241K |
2025 Q2
3 quarters
|
|
4013
TechTarget
TTGT
$268M
| $89.8K | ﹤0.01% |
23,132
-35,072
| -60% | -$161K |
2016 Q1
40 quarters
|
|
4014
Kura Sushi USA
KRUS
$503M
| $89.7K | ﹤0.01% |
1,285
-8,508
| -87% | -$571K |
2022 Q1
16 quarters
|
|
4015
iShares MSCI Taiwan ETF
EWT
$12.3B
| $89.6K | ﹤0.01% |
1,264
-3,215
| -72% | -$226K |
2024 Q4
5 quarters
|
|
4016
Tilray
TLRY
$528M
| $89.4K | ﹤0.01% |
13,817
+10,147
| +276% | +$79.1K |
2021 Q1
20 quarters
|
|
4017
Puma Biotechnology
PBYI
$508M
| $89.4K | ﹤0.01% |
13,988
-67,446
| -83% | -$435K |
2016 Q3
38 quarters
|
|
4018
Limoneira
LMNR
$216M
| $88.8K | ﹤0.01% |
6,620
-22,630
| -77% | -$314K |
2022 Q3
14 quarters
|
|
4019
Mistras Group
MG
$657M
| $88.8K | ﹤0.01% |
6,005
-13,543
| -69% | -$196K |
2016 Q3
38 quarters
|
|
4020
Willis Lease Finance
WLFC
$1.01B
| $88.7K | ﹤0.01% |
1,563
-14,733
| -90% | -$885K |
2022 Q3
14 quarters
|
|
4021
Mesa Laboratories
MLAB
$724M
| $88.6K | ﹤0.01% |
1,002
-7,184
| -88% | -$619K |
2016 Q3
38 quarters
|
|
4022
Hippo Holdings
HIPO
$832M
| $87.6K | ﹤0.01% |
3,363
-24,543
| -88% | -$699K |
2022 Q1
16 quarters
|
|
4023
Fate Therapeutics
FATE
$276M
| $87.6K | ﹤0.01% |
72,996
-235,546
| -76% | -$287K |
2017 Q1
36 quarters
|
|
|
ZEPP
4024
Zepp Health
ZEPP
$58.1M
| $87.1K | ﹤0.01% |
7,291
-2,475
| -25% | -$50.7K |
2025 Q3
2 quarters
|
|
4025
OneSpan
OSPN
$665M
| $86.9K | ﹤0.01% |
8,257
-47,989
| -85% | -$544K |
2022 Q1
16 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.